The Hope Foundation for Cancer Research named Dr. Raymond Osarogiagbon, chief scientist and director of Baptist Cancer Center’s Multidisciplinary Thoracic Oncology Program, as board chair. The Hope Foundation administers more peer-reviewed, competitive grant programs than other group foundations in the National Cancer Institute’s National Clinical Trials Network.
“We are so proud of Dr. Osarogiagbon, and we know he will be an asset to The Hope Foundation as he is to Baptist,” said Ann Bishop, system oncology administrator for Baptist. “His experience in the field and passion for curing cancer will help expand the quality of The Hope Foundation’s research and potentially save thousands of lives.”
The Hope Foundation is a public charity for the SWOG Cancer Research Network, a global cancer research community that designs and conducts publicly funded clinical trials. Founded in 1956, SWOG trials have saved more than 3 million years of life by testing new treatments, new prevention strategies and new ways to care for those who survive cancer.
At Baptist, Dr. Osarogiagbon also spearheads the Mid-South Miracle initiative, a multifaceted initiative comprising seven components for significantly reducing lung cancer deaths in the Mid-South. A community oncologist, Dr. Osarogiagbon serves as primary investigator for the Baptist Memorial Health Care/Mid-South Minority Underserved NCI Community Oncology Research Program (NCORP), and he has led the NCORP site principal investigator sessions at SWOG’s recent group meetings.
